Comparing myofascial release and kinesiotaping for period pain
Comparison of Myofascial Release and Kinesiotaping Techniques in the Management of Primary Dysmenorrhea
This will try a single session of myofascial release versus kinesiotaping to see which reduces menstrual cramps in women aged 18–30 with primary dysmenorrhea.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 46 (estimated) |
| Ages | 18 Years to 30 Years |
| Sex | Female |
| Sponsor | Medipol University Academic / other |
| Locations | 1 site (Istanbul, Beykoz) |
| Trial ID | NCT07022106 on ClinicalTrials.gov |
What this trial studies
This single-blind randomized controlled trial will randomize 46 women aged 18–30 with primary dysmenorrhea to receive either myofascial release therapy (MRT) or kinesiotaping (KT). Each participant will receive one intervention session during their most painful menstrual day. Pain and patient-reported outcomes will be measured before and after the intervention using a Visual Analog Scale (VAS) and standardized questionnaires, alongside a sociodemographic form. The trial compares the acute therapeutic effects of MRT versus KT on menstrual pain.
Who should consider this trial
Good fit: Women aged 18–30 with diagnosed primary dysmenorrhea, regular menstrual cycles for the past six months, and moderate-to-severe pain on menstrual days 1–3 who are not pregnant and not using pain medications.
Not a fit: Patients with secondary gynecological conditions, current use of pain medications, a history of pregnancy, irregular cycles, or those outside the 18–30 age range are unlikely to match or benefit from this protocol.
Why it matters
Potential benefit: If successful, the interventions could provide a simple, drug-free option to reduce menstrual pain and improve quality of life.
How similar studies have performed: Previous small trials and physiotherapy reports have suggested that kinesiotaping and myofascial release can reduce pelvic or menstrual pain, but the evidence is limited and results are mixed.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of primary dysmenorrhea, * Moderate-to-severe pain during menstrual days 1-3, * Regular menstrual cycles for past 6 months Exclusion Criteria: * Secondary gynaecological conditions, * Current use of pain medications, * History of pregnancy
Where this trial is running
Istanbul, Beykoz
- İstanbul Medipol University — Istanbul, Beykoz, Turkey (Türkiye) (Recruiting)
Study contacts
- Study coordinator: Salma Abdelzaher
- Email: salma.abdelzaher@std.medipol.edu.tr
- Phone: +90 5411086862
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.